Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
AI drug-discovery platform Isomorphic Labs has raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital. The company plans to use the capital to further develop its AI drug-design engine and advance its drug candidates into clinical trials. Isomorphic Labs was spun out of Google’s DeepMind in 2021 and builds on its breakthrough AlphaFold protein-folding technology. Open article →
- Isomorphic Labs announces Series C investment round - Isomorphic Labs
- Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
- Isomorphic Labs Raises $5 Billion for AI Drug Design
- Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round
- Isomorphic Labs announces $5 Billion Series C funding
- Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
- Isomorphic Labs raises $5 billion in its second mega-round within six months
- Sequoia and Greenoaks lead massive $5BN Series C funding round in Isomorphic Labs
- Who backed Isomorphic Labs' monster $5bn Series C?
- DeepMind spinout Isomorphic Labs lands $5B Series C to take AI-designed medicines into the clinic
- Can AI Solve All Disease? DeepMind Co-Founder Demis Hassabis Just Raised $5 Billion To Find Out
- Demis Hassabis’s Isomorphic Labs raises $5 billion, and it hasn’t tested a drug in people yet
- Google’s Isomorphic Labs Raises $5 Billion Series C From Greenoaks And Sequoia Capital
- Isomorphic Labs raises $5bn backed by Sequoia and A16z
- Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Di...
- An amazing moment at Iso as we close our Series C funding round! We founded Iso on the conviction...
- Isomorphic Labs raised $5 Billion in Series C funding from Greenoaks, Sequoia Capital and Andrees...
- We’ve closed our $5 Billion funding round co-led by Greenoaks and Sequoia Capital to build the fu...